Researchers at Penn Medicine have discovered a new, more effective method of preventing the body’s own proteins from treating nanomedicines like foreign invaders, by covering the nanoparticles with a coating to suppress the immune response that dampens the therapy’s effectiveness.
With the new coronavirus variant circulating widely, our expert urges people to get the vaccine and booster shots—and to wear a tight-fitting mask around people outside one’s household.
Mayo Clinic experts are available to offer commentary and perspective on the "new normal" as COVID-19 transitions to an endemic disease. Among Mayo Clinic experts who are available
There is growing evidence that the currently available MRNA vaccines provide some protection against the Omicron variant (B.1.1.529) of the SARS-COV-2 virus, the coronavirus that causes COVID-19. According to the CDC, preliminary results for Omicron from South Africa showed that the Pfizer vaccine provided 70% protection against COVID-19 hospitalization and 33% against infection, during the current Omicron wave. Granted, the protection is reduced compared with the Delta variant (93% for hospitalization and 80% for infection).
An additional “booster” dose of Moderna or Pfizer mRNA-based vaccine is needed to provide immunity against the Omicron variant of SARS-CoV-2, the virus that causes COVID-19, according to a study by researchers at the Ragon Institute of MGH, MIT and Harvard.
An experimental immunotherapy can temporarily reprogram patients’ immune cells to attack a specific target via only a single injection of messenger RNA (mRNA), similar to the mRNA-based COVID-19 vaccines, according to a new study from researchers in the Perelman School of Medicine at the University of Pennsylvania.
First on the list: Get vaccinated and get a booster shot if you qualify.
The National Comprehensive Cancer Network (NCCN) publishes updated guidance on vaccination and pre-exposure prophylaxis of COVID-19 for people with cancer based on latest FDA approvals and surging COVID-19 infection rates—available at NCCN.org/covid-19.
ORNL story tips: Cooler vaccine transport, bioenergy boost and radiation-resistant sensors
Cervical cancer is the only gynecologic cancer that can be prevented—and there are numerous tools to promote prevention including vaccines and tested strategies. James K. Aikins, Jr., MD, FACOG, FACS, chief of Gynecologic Oncology at Rutgers Cancer Institute of New Jersey and associate professor of Obstetrics, Gynecology and Reproductive Sciences at Rutgers Robert Wood Johnson Medical School shares more information about cervical cancer prevention through HPV vaccination, routine PAP tests and lifestyle choices.
Now more than ever, shots and vaccines are an important part of a safe and healthy childhood. The experience of getting these shots, however, can be a source of fear and anxiety—for children and even parents alike. How can families make it easier? Two Child Life specialists from Children’s Hospital Los Angeles share eight important tips.
This year the medical and research advancements from the Icahn School of Medicine at Mount Sinai and the Mount Sinai Health System ranged from COVID-19, to PTSD, to the first ever successful trachea transplant surgery. Our doctors and researchers were not only at the forefront of the pandemic providing expertise and new studies surrounding the virus, its symptoms and effects, but also excelling in revolutionary surgeries and progressive research to continue showcasing Mount Sinai as a top medical institution and medical school in the country. Here are some of Mount Sinai’s breakthrough stories of the year:
In a widely shared newsletter, Steve Kirsch, a man who promotes himself as an entrepreneur and technology expert, stated that "they've now killed close to twice as many kids from the vaccine as have died from COVID." He's also repeated this claim in an interview on The New American, a conservative news site. We find this claim false. There is no confirmed evidence of a COVID-19 vaccine causing the death of even one child.
On Dec. 22, Caroline Davis of Nashville became the first patient at Vanderbilt University Medical Center to receive injections of a new antibody combination to protect her from COVID-19.
A new study by researchers at Washington University School of Medicine in St. Louis and St. Jude Children’s Research Hospital helps explain why mRNA vaccines have been so successful at preventing severe disease.
The California State University announced today that it will require faculty, staff and students who are accessing university facilities or programs to receive a vaccine booster shot in order to be fully immunized against SARS-CoV-2, the virus that causes COVID-19, and in compliance with the university's COVID-19 vaccination policy.
As the discovery of the new omicron variant illustrates, new COVID-19 variants will continue to regularly emerge. In an effort to make sense of these new variants, scientists at Los Alamos National Laboratory have developed methods to quantify how much more or less transmissible they are, which could have far-reaching implications for public health in terms of COVID-19 risk and the vaccination levels required to obtain herd immunity.
The results of a nationwide, multicenter clinical trial led by Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health provides solid evidence for the use of plasma from convalescent patients — those who have recovered from the disease and whose blood contains antibodies against SARS-CoV-2, the virus that causes COVID-19 — as an early treatment
Newly published findings from surveys conducted last year reveal people were less interested in getting COVID-19 vaccines when they thought the vaccines were scarce. The researchers point to compassion for the vulnerable as a driving factor.
A new study from COVID researchers at Columbia and the University of Hong Kong adds more evidence that the omicron variant can evade the immune protection conferred by vaccines and natural infection.
Research Shows Vaccine Has 90 Percent Efficacy at Preventing Infections; Moderate to Severe Disease Occurred Only in Placebo Recipients
Cedars-Sinai is gathering pediatricians, parents and community members to address important questions about vaccinating children 5-11 years old against COVID-19. The free virtual event, “The Open House: FAQs on COVID-19 Vaccines for Ages 5-11,” will take place from 5-6 p.m. Wednesday, Dec. 15, on Zoom. The conversation will be recorded and available for viewing by clicking here.
Kaiser Permanente research published on December 15, 2021 in The British Medical Journal showed 2 doses of Moderna COVID-19 vaccine were highly effective against all SARS-CoV-2 variants; however, vaccine effectiveness against the delta variant moderately declined with increasing time after vaccination.
os especialistas da Mayo Clinic afirmam que, independentemente da variante, a prevenção da infecção funciona. As vacinas reduzem e previnem a hospitalização e morte de acordo com o conhecimento atual.
妙佑医疗国际(Mayo Clinic)的专家表示，无论对于哪种变异株，预防感染的措施都有效。根据现有理解，疫苗可预防并且减少住院和死亡。如果您可以接种疫苗或符合接种加强针的条件，请立即接种。
مدينة روتشستر، ولاية مينيسوتا- يقول خبراء مايو كلينك، بغض النظر عن المتحور، فإن الوقاية من العدوى تجدي نفعًا. وتقلل اللقاحات من دخول المستشفى والوفاة وتقي منهما بناءً على المعرفة الحالية. إذا كنتَ قادرًا على التطعيم أو مؤهلًا للحصول على جرعة معززة، فقم بذلك الآن.
Los expertos de Mayo Clinic dicen que, independientemente de la variante, la prevención de la infección funciona. Las vacunas reducen y previenen los casos de hospitalización y muerte, según lo que se sabe hasta ahora. Si reúnes las condiciones para vacunarte o recibir un refuerzo, hazlo ahora.
Penn Medicine’s pop-up vaccine clinics and low-tech signups provided a road map for equitable mass vaccinations, at sites from schools to churches to hardware store parking lots. Now, the health system is planning for what’s next.
A nationwide effort to adequately vaccinate 8 in 10 adolescents against the human papillomavirus (HPV) could prevent 934,000 cases of virus-associated, male oropharyngeal cancer over this century, reported investigators at The University of Texas Health Science Center at Houston (UTHealth Houston) School of Public Health in The Lancet Regional Health—Americas.
The National Institute of Allergy and Infectious Diseases awarded researchers at the Duke Human Vaccine Institute a contract that enables it to compete for projects advancing investigational vaccines to production for use in early clinical trials.
A highly anticipated clinical trial in eight sub-Saharan countries is the first to specifically evaluate the efficacy of a COVID-19 vaccine in people living with HIV, including those with poorly controlled infections. It also is the first study to evaluate the efficacy of vaccines – in this case, Moderna mRNA-1273 – against the omicron variant of SARS-CoV-2, the virus that causes COVID-19.
A long, long time ago, the BCG vaccine was approved for use against tuberculosis (TB), and it's still given to infants today. For generations, the vaccine has saved lives and prevented untold suffering.
For patients with the blood cancer multiple myeloma, vaccination against COVID-19 provides some protection against coronavirus infection but to a far lower degree than the general population of cancer survivors, a new study by Dana-Farber Cancer Institute investigators shows.
Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have identified rare, naturally occurring T cells that are capable of targeting a protein found in SARS-CoV-2 and a range of other coronaviruses.
.jpg&width=400&height=400)
A new company spawned by McMaster University innovation in the arena of vaccine manufacturing has received a grant from the Bill & Melinda Gates Foundation. Elarex Inc., based in Burlington, has been awarded a $1.2M Cdn grant from the non-profit humanitarian foundation to develop a new technology for keeping liquid mRNA vaccines safe and viable without the deep-freeze that is necessary today for storing and transporting such vaccines.
Immunologist David A. Ostrov, Ph.D., was asked by a worldwide consortium of scientists to analyze and map the locations of omicron’s mutations. His analysis for the Global Virus Network found omicron has substantially more mutations than the delta variant at four key sites within the virus.
Mayo Clinic experts say, regardless of the variant, prevention of infection works. The vaccines reduce and prevent hospitalization and death based on current knowledge. If a person can get vaccinated or is eligible for a booster, do it now. But what about these variants? Why do they show up, and how? Here is what Mayo Clinic experts are saying:
The combination of two monoclonal antibodies, called Evusheld, was authorized as a pre-exposure prophylaxis to prevent COVID-19 in adults and children 12 years and older who have compromised immune systems or a history of severe adverse reactions to a COVID-19 vaccine.
Many parents have been concerned about reports of myocarditis—heart inflammation—in some young people who have received a COVID-19 vaccine. This worry is understandable. But there’s also reassuring news: Heart inflammation after the vaccine is a very rare event.
Antibodies against the SARS-CoV-2 spike protein produced by the immune system can help identify and fend off future infections, but not all antibodies are the same.
Rush physicians and scientists can explain how SARS-CoV-2 is studied through weekly genomic sequencing, how it has changed over time and how that knowledge can be applied to such concerns as outbreaks, breakthrough cases and the arrival of new variants.
A combination of vaccination and naturally acquired infection appears to boost the production of maximally potent antibodies against the COVID-19 virus, new UCLA research finds.
The study, called COVID CommUNITY- First Nations, will collect, analyze, and report data relating to COVID-19 vaccine effectiveness and safety, as well as explore hesitancy in three First Nations communities in Canada: Six Nations of the Grand River in southwestern Ontario; Lac La Ronge Indian Band in Saskatchewan; and Wendake in Quebec.
Human trials are set to begin for two next-generation COVID-19 vaccines developed by a team of scientists at McMaster University.
According to a new study by researchers at the University of Illinois Chicago, approximately 3 in 20 health care workers surveyed reported being hesitant about getting their COVID-19 vaccinations. The study also showed workers’ vaccine decisions were likely to be influenced by their colleagues.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
